Thomas Bulleit > Ropes & Gray LLP > Washington DC, United States > Lawyer Profile
Ropes & Gray LLP Offices
2099 PENNSYLVANIA AVENUE, NW
WASHINGTON, DC 20006-6807
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Thomas Bulleit
Work Department
Health Care
Position
Partner
Career
Tom Bulleit represents a wide range of clients in all sectors of the healthcare industry, from academic medical centers and companies engaged in biomedical research and development, to large and small manufacturers of medical devices and pharmaceuticals, to HMOs and other healthcare payors, to hospitals, hospices, physicians, physician practice management companies, physical therapists, and other hands-on providers of healthcare, to niche companies offering unconventional services such as e-health connectivity. Tom’s practice focuses on legal and regulatory compliance, coverage, and reimbursement, especially under Medicare and other federal healthcare programs but also under state licensing and regulatory regimes, as a counselor, a business lawyer, and an advocate.
A primary focus of Tom’s practice has been compliance with health regulatory requirements, especially the healthcare fraud and abuse laws. He strives to provide counseling that allows clients to meet legal requirements while still engaging in competitive business arrangements. His counseling practice includes internal client audits and the development of compliance plans, policies, and standard operating procedures. Because the fraud and abuse rules often dictate or heavily influence the permissibility of financial relationships in the healthcare industry, Tom’s regulatory experience has led his healthcare and investor clients to engage him extensively for strategic analysis, development and negotiation of business deals, including academic affiliation agreements between medical schools and their teaching hospitals, and between academic medical centers and community healthcare providers, contracts for healthcare professional services and employment, medical product purchase and sale, discounts and rebates,asset purchases, and regulatory “due diligence” in both the public and private company arenas. Tom also advises in other key areas of health regulation, including coverage and reimbursement, provider payment sunshine laws, digital health and information privacy, and clinical research. He also represents clients who are under investigation by the U.S. Department of Health and Human Services Office of Inspector General, the U.S. Department of Justice, and state Attorneys General, including the negotiation and implementation of Corporate Integrity Agreements and Deferred Prosecution Agreements.
Tom is a graduate of the National Health Lawyers Association’s Masters Program in healthcare fraud and abuse. He has often spoken and authored numerous articles in the areas of technology transfer and healthcare fraud and abuse, including publications in the Food and Drug Law Journal, Academic Medicine and Compliance Today. He was elected to three terms as Chair of the Health Law Section of the District of Columbia Bar, and to a total of six years as a member of that organization’s steering committee.
Memberships
- Member, American Health Lawyers’ Association
- Member, National Association of College and University Attorneys
Education
- JD, University of Michigan Law School, 1985
- AB, cum laude, Yale University, 1979
Top Tier Firm Rankings
- Investment fund formation and management > Alternative/hedge funds
- Dispute resolution > E-discovery
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Healthcare > Service providers
Firm Rankings
- Finance > Capital markets: high-yield debt offerings
- Finance > Capital markets: equity offerings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Tax > Not-for-profit (nonprofit and tax exempt organizations)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Securities litigation: defense
- M&A/corporate and commercial > Shareholder activism
- Tax > US taxes: non-contentious
- Antitrust > Cartel
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (International Trade Commission)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Government > State attorneys general
- Labor and employment > Workplace and employment counseling
- Finance > Capital markets: high-yield debt offerings
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Finance > Structured finance: derivatives and structured products
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Antitrust > Civil litigation/class actions: defense
- Tax > US taxes: contentious
- M&A/corporate and commercial > Venture capital and emerging companies
- Finance > Financial services regulation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Structured finance: securitization
- International Trade > Customs, export controls and economic sanctions